Galectin-3 regulates the expression of tumor glycosaminoglycans and increases the metastatic potential of breast cancer
Nenhuma Miniatura disponível
Data
2019
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Galectin-3 (Gal-3) is a multifunctional β-galactoside-binding lectin that once synthesized is expressed in the nucleus, cytoplasm,
cell surface, and extracellular environment. Gal-3 plays an important role in breast cancer tumors due to its ability to promote
interactions between cell-cell and cell-extracellular matrix (ECM) elements, increasing tumor survival and metastatic dissem ination. Still, the mechanism by which Gal-3 interferes with tumor cell migration and metastasis formation is complex and not
fully understood. Here, we showed that Gal-3 knockdown increased the migration ability of 4T1 murine breast cancer cellsin vitro.
Using the 4T1 orthotopic breast cancer spontaneous metastasis mouse model, we demonstrated that 4T1-derived tumors were
significantly larger in the presence of Gal-3 (scramble) in comparison with Gal-3 knockdown 4T1-derived tumors. Nevertheless,
Gal-3 knockdown 4T1 cells were outnumbered in the bone marrow in comparison with scramble 4T1 cells. Finally, we reported
here a decrease in the content of cell-surface syndecan-1 and an increase in the levels of chondroitin sulfate proteoglycans such as
versican in Gal-3 knockdown 4T1 cells both in vitro and in vivo. Overall, our findings establish that Gal-3 downregulation during
breast cancer progression regulates cell-associated and tumor microenvironment glycosaminoglycans (GAGs)/proteoglycans
(PG), thus enhancing the metastatic potential of tumor cells.
Descrição
Palavras-chave
Citação
PEREIRA, Jonathas Xavier et al. Galectin-3 regulates the expression of tumor glycosaminoglycans and increases the metastatic potential of breast cancer. Journal of Oncology, Cairo, v. 2019, e9827147, 2019. DOI: 10.1155/2019/9827147. Disponível em: https://onlinelibrary.wiley.com/doi/10.1155/2019/9827147. Acesso em: 21 jan. 2025.